WO2024003792 - VIRAL DETECTION ASSAYS
National phase entry is expected:
Publication Number
WO/2024/003792
Publication Date
04.01.2024
International Application No.
PCT/IB2023/056721
International Filing Date
29.06.2023
Title **
[English]
VIRAL DETECTION ASSAYS
[French]
DOSAGES DE DÉTECTION VIRALE
Applicants **
CRISPR THERAPEUTICS AG
Inventors
GUDEY, Shyam Kumar
VERMA, Atul
SRA, Kuldip Singh
Priority Data
63/356,833
29.06.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5101 | |
| EPO | Filing, Examination, Granting | 90677 | |
| Japan | Filing, Examination, Granting | 4814 | |
| South Korea | Filing, Examination, Granting | 6927 | |
| USA | Filing, Examination, Granting | 33390 |
Total:
140,909
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Methods, compositions and kits for detection of one or more of Human Parvovirus B19 (B19), Human Herpes Virus 6 (HHV6), Human Herpes Virus 7 (HHV7), Human Herpes Virus 8 (HHV8), Epstein Barr Virus (EBV), and Hepatitis A Virus (HAV) in sample(s) are disclosed herein.[French]
L'invention concerne des méthodes, des compositions et des kits permettant la détection d'un ou plusieurs virus parmi le parvovirus humain B19 (B19), le virus de l'herpès humain 6 (HHV6), le virus de l'herpès humain 7 (HHV7), le virus de l'herpès humain 8 (HHV8), le virus d'Epstein-Barr (EBV) et le virus de l'hépatite A (HAV) dans un ou plusieurs échantillons.